Areas of Interest


We are actively seeking to expand our pipeline and product portfolio based on the following criteria:


Women’s Health

Territory:

European Union (EU), Russia and Commonwealth of Independent States

(CIS), China, Latin-America

We are searching for:

clinical phase projects with at least an efficacy signal, registered or

marketed products

We offer:

co-development and co-financing, registration, participation in P&R

approval,sales and marketing


Central Nervous System

Territory:

European Union (EU), Russia and Commonwealth of Independent

States(CIS), China

We are searching for:

preclinical and early clinical phase projects (Ph1, Ph2a) in dementia,

autism and obesity, registered or marketed products in all CNS indications

We offer:

acquisition of early developments, co-development and co-financing,

registration, participation in P&R approval, sales and marketing


Other therapy areas (Cardiovascular, Rheumatology, Respiratory, Anti-infectives), OTC products

Territory:

Central and Eastern Europe (CEE), Russia and Commonwealth of

Independent States (CIS), China

We are searching for:late-stage clinical phase projects, registered or marketed products
We offer:

co-financing, registration, participation in P&R approval, sales and

marketing

JOINT DEVELOPMENT

We offer early Research and Development collaborations in dementia, autism and obesity and participation in the design and running of clinical trials in strategically selected areas within the Central Nervous System and Gynecology.


TECHNOLOGY TRANSFER & MANUFACTURING

With the ability to manufacture a broad range of finished dosage forms in state of the art EMA and FDA approved facilities in Hungary, Poland, Romania, Russia and Germany Richter is open to discuss manufacturing opportunities of innovative license-in projects. Richter is also actively searching for contract manufacturing opportunities for his state-of-the-art manufacturing facilities with a special emphasis on contract development and manufacturing of steroid APIs and finished dosage forms.